InMode (NASDAQ:INMD) Announces Earnings Results

InMode (NASDAQ:INMD) issued its earnings results on Tuesday. The healthcare company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.42 by $0.04, FiscalAI reports. The company had revenue of $103.85 million during the quarter, compared to analysts’ expectations of $104.64 million. InMode had a net margin of 41.04% and a return on equity of 14.50%.

InMode Trading Up 0.3%

Shares of NASDAQ INMD opened at $15.12 on Tuesday. The firm has a market cap of $955.74 million, a PE ratio of 7.00 and a beta of 2.19. InMode has a 1-year low of $13.14 and a 1-year high of $19.78. The company has a fifty day moving average price of $14.66 and a 200 day moving average price of $14.69.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on INMD shares. Weiss Ratings reissued a “sell (d+)” rating on shares of InMode in a research note on Thursday, January 22nd. Wall Street Zen cut shares of InMode from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. UBS Group cut their target price on shares of InMode from $16.25 to $16.00 and set a “neutral” rating on the stock in a report on Thursday, November 6th. Canaccord Genuity Group set a $15.00 price target on shares of InMode and gave the stock a “hold” rating in a research report on Wednesday, December 17th. Finally, BTIG Research restated a “neutral” rating on shares of InMode in a research report on Monday, January 26th. One research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $16.60.

Institutional Trading of InMode

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Two Sigma Investments LP acquired a new stake in shares of InMode in the 3rd quarter valued at approximately $398,000. Tower Research Capital LLC TRC grew its position in shares of InMode by 810.4% in the 2nd quarter. Tower Research Capital LLC TRC now owns 59,631 shares of the healthcare company’s stock valued at $861,000 after acquiring an additional 53,081 shares during the period. Engineers Gate Manager LP increased its stake in shares of InMode by 197.7% during the 2nd quarter. Engineers Gate Manager LP now owns 103,779 shares of the healthcare company’s stock worth $1,499,000 after purchasing an additional 68,921 shares during the last quarter. PDT Partners LLC increased its position in InMode by 249.6% during the 2nd quarter. PDT Partners LLC now owns 48,226 shares of the healthcare company’s stock worth $696,000 after buying an additional 34,432 shares during the period. Finally, Sei Investments Co. lifted its holdings in shares of InMode by 40.0% during the second quarter. Sei Investments Co. now owns 50,849 shares of the healthcare company’s stock worth $734,000 after buying an additional 14,530 shares in the last quarter. Institutional investors and hedge funds own 68.04% of the company’s stock.

InMode Company Profile

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.